Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib
2012 · Journal of Lipid Research · 56 citations
https://doi.org/10.1194/jlr.m032615
Y
Yale Mitchel
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
108
Papers
5.9K
Citations
38
h-index
64
i10-index
Yale Mitchel is an academic researcher from Merck & Co., Inc., Rahway, NJ, USA (United States). The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Diabetes, Cardiovascular Risks, and Lipoproteins & Cancer, Lipids, and Metabolism. The author has an h-index of 38, co-authored 92 publications.
Papers by this author
worksVAP II analysis of lipoprotein subclasses in mixed hyperlipidemic patients on treatment with ezetimibe/simvastatin and fenofibrate
2008 · Journal of Lipid Research · 15 citations
https://doi.org/10.1194/jlr.p800034-jlr200
Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes
2016 · Lipids in Health and Disease · 3 citations
https://doi.org/10.1186/s12944-016-0282-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat